Company / Current Assets
Idexx Laboratories Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.4B
FY2025
5-year range
$955.7M / $1.5B
FY2021-FY2025
Trend
+1.0%
vs FY2024
Sector context
#61 of 165
Health Care
What the data says
At $1.4B, Idexx Laboratories's current assets ranks #61 of 165 in the Health Care sector. Current Assets has fluctuated over the past 10 years, ranging from $654M in FY2018 to $1.5B in FY2023.
Based on SEC 10-K filings.
$1.4B in FY2025 with a 5-year CAGR of +5.9%.
Declined from $1.5B to $1.4B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +8.7%
- 5-Year CAGR
- +5.9%
- 10-Year CAGR
- -
Sector benchmark
#61 of 165 in Health CareTop 37% of 165This company $1.4B Sector average $5.2B
▼
-73.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +5.9%, indicating consistent growth.
- In FY2025, current assets increased 1.0% year-over-year.
- Ranks #61 out of 165 companies in the Health Care sector.
- Peak current assets was recorded in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 4.60 (safe zone, above 2.9 threshold)
- Strong profit margin: 24.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 65.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.4B | +1.0% |
| FY2024 | $1.4B | -6.4% |
| FY2023 | $1.5B | +35.7% |
| FY2022 | $1.1B | +15.3% |
| FY2021 | $955.7M | -10.1% |
| FY2020 | $1.1B | +56.4% |
| FY2019 | $679.6M | +3.9% |
| FY2018 | $654.2M | -32.7% |
| FY2017 | $972.0M | +14.9% |
| FY2016 | $845.6M | +2.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026